A Clinical Trial to Find Out V81444's Side Effects and Blood Levels in Healthy Men

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Parkinson's Disease
Interventions
DRUG

V81444

"Single ascending oral doses of V81444 and placebo~Multiple ascending oral doses of V81444 and placebo"

Trial Locations (1)

NW10 7EW

Hammersmith Medicines Research, London

All Listed Sponsors
lead

Vernalis (R&D) Ltd

INDUSTRY

NCT01634568 - A Clinical Trial to Find Out V81444's Side Effects and Blood Levels in Healthy Men | Biotech Hunter | Biotech Hunter